SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25,
1996
McKESSON CORPORATION
- --------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-13252 94-3207296
- --------------------------------------------------------------
(State or other (Commission File (I.R.S. Employer
jurisdiction of Number) Identification
incorporation) Number)
McKesson Plaza
One Post Street
San Francisco, California 94104
- --------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(415) 983-8300
- --------------------------------------------------------------
(Registrant's telephone number, including area code )
Item 5. Other Events.
------------
On April 25, 1996, the Registrant announced that Mark A. Pulido has
been elected President, Chief Operating Officer and a Director of
the Registrant, effective May 20, 1996. He succeeds David E.
McDowell, who announced his plans to resign as president earlier
this month. The text of the press release regarding this
announcement is set forth in Exhibi
(99) to this Current Report on Form 8-K.
Item 7. Financial Statements, Pro Forma Financial Infomation
----------------------------------------------------
and Exhibits.
-------------
(c) Exhibits
--------
(99) Press Release issued by McKesson
Corporation on April 25, 1996
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
McKESSON CORPORATION
(Registrant)
Dated: April 29, 1996 BY /s/NANCY A. MILLER
Vice President and Secretary
EXHIBIT INDEX
Exhibit
No. Title
- ------- ---------------------------------------
(99) Press Release issued by McKesson Corporation on April 25,
1996.
<PAGE>
Exhibit (99.1)
McKesson Corp.
One Post Street, San Francisco CA 94104-5296 Tel 415 983
8300
Contact: Janet Bley
(415) 983-9357
MARK A. PULIDO ELECTED PRESIDENT AND
CHIEF OPERATING OFFICER OF McKESSON
SAN FRANCISCO, Thursday, April 25, 1996 -- McKesson Corp. announced
today the election of Mark A. Pulido, 43, as its president and
chief operating officer, effective May 20, 1996. Pulido also was
elected a director of McKesson. He will succeed David E. McDowell,
who announced his plans to resign as president earlier this month.
McDowell will continue with McKesson in a senior advisory capacity.
Pulido has worked in the healthcare industry his entire
career. After completing graduate studies, he spent 13 years in
the wholesale pharmaceutical distribution business, starting with
McKesson Drug Company. He joined Red Line Healthcare Corporation,
a Sandoz affiliate and the nation's largest provider of medical
supplies and reimbursement services to the long-term care industry,
where he rose to the post of chairman, president and chief
executive officer. Most recently he served as chief executive
officer of Sandoz Pharmaceuticals Corporation where he was
responsible for all aspects of that company's U.S. pharmaceutical,
consumer products and generic drug business.
In making the announcement, Alan Seelenfreund, McKesson's
chairman and chief executive officer, said, "We are very pleased to
have Mark Pulido join the McKesson senior management team. He is
uniquely qualified to provide the leadership that is essential for
this critical position. His broad industry experience and success
will enable us to continue to find innovative solutions to our
provider and supplier customers' needs. Additionally, his approach
to business and his management style are an excellent fit with
the culture of McKesson. We know Mark well as a former colleague,
competitor and partner. He is a proven and highly skilled
executive who can lead our businesses to achieve superior
performance."
Mark Pulido said, "McKesson is a uniquely positioned market
leader with a strong customer focus and excellent ability to
deliver results for pharmaceutical manufacturers and providers. I
am excited about being on the McKesson team as we capture growth
and create value by managing the flow of pharmaceuticals from
manufacturer to patient."
Pulido earned a B.S. degree from the University of Arizona
College of Pharmacy and an M.S. in pharmacy administration from the
University of Minnesota College of
Pharmacy.
McKesson Corp., with annual revenues of more than $13 billion,
is a leading provider of pharmaceuticals and health care products
and services. Through McKesson Drug Company, McKesson Health
Systems and a Canadian subsidiary, Medis Health and Pharmaceutical
Services, McKesson is the largest distributor of pharmaceuticals
and health care products in North America. Headquartered in San
Francisco, McKesson is listed on the New York and Pacific stock
exchanges (MCK).
# # #
McKesson news releases are available at no charge through
McKesson's NewsOnDemand fax service.
To immediately receive an index of available releases, call
1-800-344-6495 and press 2.
